THNR ETF
$24.96
Amplify Weight Loss Drug & Treatment ETF
AUM$4M
TER0.59%
Holdings22

✓All holdings
✓Overlap Analysis
✓ETF Screener
✓Compare ETFs
Showing 10 of 22 holdings(as of Jan 30, 2026)Top 10 Weight: 71.84%
THNR ETF Top Holdings
THNR holdings top 10 positions. The top 10 holdings account for 71.8% of the fund, led by Eli Lilly & Co at 13.0%, Novo Nordisk A/S ADR at 11.2%, Amgen Inc. at 7.4%.
THNR portfolio concentration is relatively high, with the top 10 representing 71.8% of total assets. The largest sector exposure is Health Care at 76.7%.
THNR sector allocation provides a detailed breakdown. THNR overlap tool shows how holdings compare to other funds in your portfolio.